The PE Ratio as of September 2024 (TTM) for Applied Molecular Transport Inc. (AMTI) is -0.14

According to Applied Molecular Transport Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.14. This represents a change of -17.40% compared to the average of -0.17 of the last 4 quarters.

Applied Molecular Transport Inc. (AMTI) Historical PE Ratio (quarterly & annually)

How has AMTI PE Ratio performed in the past?

The mean historical PE Ratio of Applied Molecular Transport Inc. over the last ten years is -8.16. The current -0.14 PE Ratio has changed 70.50% with respect to the historical average. Over the past ten years (40 quarters), AMTI's PE Ratio was at its highest in in the March 2023 quarter at -0.12. The PE Ratio was at its lowest in in the March 2019 quarter at -19.22.

Applied Molecular Transport Inc. (AMTI) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Applied Molecular Transport Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Applied Molecular Transport Inc. (AMTI) Average PE Ratio

How has AMTI PE Ratio performed in the past?

The current PE Ratio of Applied Molecular Transport Inc. (AMTI) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Applied Molecular Transport Inc. (AMTI) PE Ratio vs. Peers

How is AMTI’s PE Ratio compared to its peers?

Applied Molecular Transport Inc.’s PE Ratio is greater than Catalyst Biosciences, Inc. (-0.44), greater than Aileron Therapeutics, Inc. (-2.21), less than Bio-Path Holdings, Inc. (-0.14), greater than Benitec Biopharma Inc. (-1.08), less than Aerovate Therapeutics, Inc. (0), greater than Adagene Inc. (-0.62), greater than Acrivon Therapeutics, Inc. Common Stock (-2.86), greater than Rezolute, Inc. (-4.23), greater than AN2 Therapeutics, Inc. (-3.80), greater than Inhibikase Therapeutics, Inc. (-0.47), less than Sio Gene Therapies Inc. (0), greater than Kaleido Biosciences, Inc. (-0.55), greater than Tempest Therapeutics, Inc. (-4.77), less than Lipella Pharmaceuticals Inc. (0), greater than Senti Biosciences, Inc. (-0.88), less than Fennec Pharmaceuticals Inc. (-0.00), greater than Monopar Therapeutics Inc. (-0.23), less than null (54.24), greater than null (-1.18),

Build a custom stock screener for Applied Molecular Transport Inc. (AMTI) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Applied Molecular Transport Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Applied Molecular Transport Inc. (AMTI) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Applied Molecular Transport Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.